牛牛AI助理已提取核心訊息
Patrick J Heron, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a purchase of 21,052 shares of common stock on March 4, 2024. The transaction was conducted in the open market at a price of $9.50 per share. Following this transaction, the total number of shares beneficially owned by Heron through direct and indirect holdings is 23,688. The indirect shares are held by Frazier Life Sciences VIII, L.P. This acquisition reflects a significant investment in the company, with the total value of the purchased shares amounting to approximately $199,994.
Patrick J Heron, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a purchase of 21,052 shares of common stock on March 4, 2024. The transaction was conducted in the open market at a price of $9.50 per share. Following this transaction, the total number of shares beneficially owned by Heron through direct and indirect holdings is 23,688. The indirect shares are held by Frazier Life Sciences VIII, L.P. This acquisition reflects a significant investment in the company, with the total value of the purchased shares amounting to approximately $199,994.
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的帕特里克·赫倫於2024年3月4日完成了對21,052股普通股的購買。該交易在公開市場上進行，價格爲每股9.50美元。此次交易後，Heron通過直接和間接持股實益擁有的股份總數爲23,688股。間接股份由弗雷澤生命科學VIII, L.P持有。此次收購反映了對該公司的重大投資，購買的股份總價值約爲199,994美元。
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的帕特里克·赫倫於2024年3月4日完成了對21,052股普通股的購買。該交易在公開市場上進行，價格爲每股9.50美元。此次交易後，Heron通過直接和間接持股實益擁有的股份總數爲23,688股。間接股份由弗雷澤生命科學VIII, L.P持有。此次收購反映了對該公司的重大投資，購買的股份總價值約爲199,994美元。
有用
沒用